glp-1 thyroid cancer risk There is no conclusive evidence linking medications to in the general population. But for people with certain rare family syndromes the picture is different, which is why these GLP-1 and Family History of

GLP-1s interact with receptors in the brain to promote satiety and reduce appetite, making individuals feel fuller for longer periods and helping to manage weight

( This highlights a gap in the research, as PsA has been less extensively studied with GLP-1RAs, and further studies are needed to confirm whether GLP-1RAs provide similar immunomodulatory and metabolic benefits in PsA as they do in PsO

10.1016/j.neuron.2014.02.031 Neuron 118 MinatoharaK.AkiyoshiM.OkunoH

The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort

however these adverse reactions were tolerable and mostly temporary

People who discontinue earlier, whether due to side effects, cost, or other reasons, arent reflected in these averages, so your own experience may look different from the published numbers